Focusing on Multiple Myeloma
The AACR is partnering with Takeda to support research to broaden our understanding of multiple myeloma and develop better treatments.
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell important for a healthy immune system. Over time, myeloma cells collect in the bone marrow, forming tumors in many of the body’s bones. These tumors may keep the bone marrow from making enough healthy blood cells and weaken the bone.
While the causes of
multiple myeloma are not fully understood, it is more common in older people, especially men, and African-Americans. Some common symptoms include bone pain, weakness or fatigue, weight loss, frequent infections, and frequent urination.
The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program
estimates that more than 30,000 people living in the United States were diagnosed with multiple myeloma in 2017 and that more than 12,500 died of the disease.
March is Multiple Myeloma Awareness Month.
What is the AACR Doing in This Area?
In 2017, the AACR presented the AACR-Pfizer Fellowship in Immuno-oncology Research to a multiple myeloma-focused project. Sabarinath Venniyil Radhakrishnan, MD, of the University of Utah won the fellowship for his project, "Chimeric antigen receptor (CAR) T cell therapy for multiple myeloma."
In 2016, the AACR teamed up with
Takeda Oncology to offer two fellowships in the area of multiple myeloma research. The AACR-Takeda Oncology Fellowships in Multiple Myeloma Research are a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct multiple myeloma-based research and to establish a successful career path in this field. The partnership will offer two additional fellowships in 2018.
Takeda is a long-standing partner of the AACR, including as a
Leadership Sustaining Member. The company has donated over $4 million to support AACR initiatives since 1999.
Last year the AACR provided over $49 million in grants and awards funding lifesaving cancer research. There are many ways you can support our mission to prevent and cure all cancers.